BRIEF published on 01/31/2025 at 08:05, 10 months 5 days ago Median Technologies unveils its 2024 financial results and its 2025 outlook Financial Results FDA Approval Median Technologies Eyonis™ LCS Expansion 2025
BRIEF published on 01/31/2025 at 08:05, 10 months 5 days ago Median Technologies dévoile ses résultats financiers 2024 et ses perspectives 2025 Résultats Financiers Median Technologies Eyonis™ LCS FDA Approbation Expansion 2025
PRESS RELEASE published on 01/31/2025 at 08:00, 10 months 5 days ago Inside Information / Other news releases Median Technologies reports 2024 financial indicators and 2025 outlook, including eyonis™ LCS FDA clearance and iCRO revenue growth. Strategic milestones and new financing agreements drive towards 2025 goals Financial Indicators Median Technologies Eyonis LCS 2025 Outlook ICRO Revenue Growth
PRESS RELEASE published on 01/31/2025 at 08:00, 10 months 5 days ago Informations privilégiées / Autres communiqués Median Technologies communique ses indicateurs financiers clés 2024 et perspectives 2025, incluant des avancées sur eyonis™ LCS pour le dépistage du cancer du poumon Indicateurs Financiers Median Technologies Cancer Du Poumon Eyonis LCS Perspectives 2025
BRIEF published on 01/24/2025 at 08:05, 10 months 12 days ago Median Technologies Secures Up to €47.5 Million for AI Lung Cancer Diagnostics European Investment Bank Median Technologies AI Lung Cancer Diagnostics Eyonis™ EU And US Commercialization
BRIEF published on 01/24/2025 at 08:05, 10 months 12 days ago Median Technologies lève jusqu'à 47,5 millions d'euros pour le diagnostic du cancer du poumon par l'IA Banque Européenne D'investissement Technologies Médianes Eyonis™ Diagnostic Du Cancer Du Poumon Par IA Commercialisation Dans L'UE Et Aux États-Unis
PRESS RELEASE published on 01/24/2025 at 08:00, 10 months 12 days ago Inside Information / Other news releases Median Technologies secures up to €47.5 million for eyonis™ AI lung cancer diagnostic regulatory filings & U.S./EU commercialization. New financing & operational enhancements drive profitability & extend cash runway into Q4, 2025 AI Commercialization Median Technologies Lung Cancer Diagnostic Eyonis
PRESS RELEASE published on 01/24/2025 at 08:00, 10 months 12 days ago Informations privilégiées / Autres communiqués Median Technologies finalise des financements de 47,5 millions d'euros pour approuver et commercialiser eyonis™ LCS aux États-Unis et en Europe. Nouveaux prêts de la BEI et financement d'IRIS soutiennent le projet Financement IRIS Median Technologies BEI Eyonis LCS
BRIEF published on 11/26/2024 at 17:50, 1 year ago Median Technologies présente le diagnostic du cancer du poumon par IA au RSNA 2024 Essais Cliniques Eyonis™ LCS RSNA 2024 Diagnostics Basés Sur L'IA Dépistage Du Cancer Du Poumon
BRIEF published on 11/26/2024 at 17:50, 1 year ago Median Technologies Showcases AI Lung Cancer Diagnostic at RSNA 2024 Clinical Trials Eyonis™ LCS RSNA 2024 AI-powered Diagnostics Lung Cancer Screening
Published on 12/05/2025 at 02:35, 9 hours 15 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 10 hours 50 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 12 hours 45 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 12 hours 50 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 11:08, 41 minutes ago Linedata Services: Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital social
Published on 12/05/2025 at 10:30, 1 hour 20 minutes ago Tradegate Exchange and Börse Berlin merge to form Tradegate BSX
Published on 12/05/2025 at 10:15, 1 hour 34 minutes ago Wuxi’s Liangxi District: Where 3,000 Years of Jiangnan Culture Thrives
Published on 12/05/2025 at 09:40, 2 hours 9 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 08:45, 3 hours 5 minutes ago Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 3 hours 5 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 3 hours 7 minutes ago ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 17 hours 35 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 17 hours 50 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
